RxDoctor Payments Data

Kimberly Loomis

Psychiatric/Mental Health · East Lansing, MINPI 1679049308

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 288 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,599in general payments, 2019–2025

Across 288 payments — averaging $19.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$660
  • AbbVie$640
  • Alkermes, Inc.$599
  • Supernus Pharmaceuticals, Inc.$478
  • Johnson & Johnson$440
  • Vanda Pharmaceuticals Inc.$391
  • plus $2K from 22 others

What the payments were for

  • Food & beverage$5,54399%
  • Education$551%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,599 in reported general payments places this provider in the 90th percentile of 638 psychiatric/mental health providers in Michigan.

See all psychiatric/mental health providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole14$19,618
Gabapentin18$276
Aripiprazole14$228
Mirtazapine11$190
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$174
Atorvastatin Calcium11$166
Sertraline Hcl12$119
Metformin Hcl15$56
Fluoxetine Hcl11$55

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$660$19,61814 claims
Almatica Pharma LLCSertraline Hcl$26$11912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 638 psychiatric/mental health providers in Michigan.

Other psychiatric/mental health in East Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →